The U.S. Food and Drug Administration on Thursday gave full approval to the Alzheimer’s drug Leqembi, clearing the way for insurance coverage of the pricey drug. “The full FDA approval will open the floodgates for people with early Alzheimer’s to get this drug. It’s a big deal because it’s very expensive at $26,500 per year,”…  read on >  read on >

Could swings in your blood fat levels increase your chances of being diagnosed with Alzheimer’s disease? Yes, suggests a new study that found fluctuating cholesterol levels among older adults may increase the risk for Alzheimer’s disease and other dementias. Those who had the most fluctuations in cholesterol had a 19% higher risk of developing Alzheimer’s…  read on >  read on >

Several companies are selling copycat food items that have the potential to trick people, including children, into consuming dangerous quantities of cannabis. On Wednesday the U.S. Food and Drug Administration and the Federal Trade Commission warned six companies about selling these copycat food products that contain delta-8 tetrahydrocannabinol, also known as delta-8 THC, a substance…  read on >  read on >

As you stare down your freshman year of college and contemplate living away from home, you’re probably facing a few “firsts”: First roommate who isn’t a sibling; first time fending for yourself to make sure you’re eating properly; and if you have nasal allergies, food allergies or asthma, this could be the first time you’re…  read on >  read on >

Under the surface of your favorite swimming pool, beach and lakes, hazards too small to be seen by the naked eye may await. And these bacteria, viruses and parasites can turn a refreshing plunge into a nasty infection. “There’s a variety of microorganisms that can make recreational activities in water less than fun,” said Dr.…  read on >  read on >

The trendy weight-loss drug Ozempic could be dangerous for a patient undergoing anesthesia for an operation, according to a new warning from the American Society of Anesthesiologists. Semaglutide (Ozempic, Wegovy) and other drugs of their class known as GLP-1 receptor agonists cause digestion to slow down, which decreases hunger and reduces how much people eat.…  read on >  read on >

Fewer teens consider themselves overweight and more underestimate what they weigh, a perception concerning to experts worried about childhood obesity. These trends could reduce the effectiveness of public health interventions meant to help young people lose weight, researchers warn. Their findings were published July 3 in the journal Child and Adolescent Obesity. “Young people who…  read on >  read on >